Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
-
Clinical Trial Information
Trial Contact: Simoni, Christine; Frankos, Marie; Rodriguez Saavedra, Carlis M; Caldwell, Chloe M
Trial Phone: 321.841.7293 ; 321.841.7303 ; 321.841.6764 ; (321)841.1107
-
IRB No: W22.045.03
Protocol Abbrev: STaRT Registry
Principal Investigator: Catherine E. Mercado, MD
Age Group: Adult;Pediatric
Secondary Protocol No: GammaTile Registry, GTM-101
Treatment: GammaTile-Surgically Targeted Radiation Therapy
Therapies Involved: Surgery
ClinicalTrials.gov ID: NCT04427384
-
Objective
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
-
Key Eligibility
-Ages Eligible for Study: Child, Adult, Older Adult
-Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.
-Willing and able to provide informed consent and to participate in all evaluations.
